BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Hepatol. Oct 27, 2026; 18(10): 124749
Published online Oct 27, 2026. doi: 10.4254/wjh.124749
Table 1 Baseline characteristics of enrolled patients, n (%) or median (interquartile range) or mean ± SD
Characteristics
AF (n = 220)
AP (n = 222)
P value
Male164 (74.5)154 (69.4)0.226
Age (≥ 60 years)105 (47.7)121 (54.5)0.154
Etiology of cirrhosis
    Hepatitis B100 (45.5)97 (43.7)0.710
    Alcohol65 (29.5)62 (27.9)0.707
    Autoimmune16 (7.3)14 (6.3)0.686
    Schistosomiasis7 (3.2)11 (5.0)0.346
    Wilson’s disease12 (0.9)4 (1.8)0.685
    MASLD10 (4.5)12 (5.4)0.678
    Hepatitis C13 (1.4)1 (0.5)0.371
    Cryptogenic cirrhosis17 (7.7)21 (9.5)0.516
Type of GEV
    EV201 (91.4)209 (94.1)0.259
    GV205 (93.2)198 (89.2)0.139
        GOV1149 (67.7)139 (62.6) 0.259
        GOV223 (10.5)30 (13.5) 0.322
        GOV314 (6.4)16 (7.2) 0.724
        IGV117 (7.7)13 (5.9) 0.434
        IGV212 (0.9)0 (0.0) 0.247
Child-Pugh class
    A141 (64.1)139 (62.6)0.747
    B + C79 (35.9)83 (37.7)
HVPG (≥ 12 mmHg)286 (51.5)101 (56.7)0.329
Diabetes65 (29.3)58 (26.1)0.423
Hypertension53 (23.9)58 (26.1)0.622
Portal vein thrombosis46 (20.7)51 (23.0)0.600
Ascites141 (63.5)150 (67.6)0.441
BMI (kg/m2)22.25 (20.53, 24.28)22.09 (20.28, 24.52)0.831
ALT (U/L)325.5 (19.0, 34.8)27.0 (20.0, 36.3)0.414
AST (U/L)334.0 (28.0, 45.8)36.0 (30.0, 46.0)0.205
Albumin (g/L)37.9 ± 5.137.7 ± 4.90.593
Total bilirubin (μmol/L)320.5 (13.3, 27.8)18.1 (14.3, 25.1)0.754
PT (second)314.9 (14.0, 15.8)14.7 (14.1, 15.8)0.608
WBC count (109/L)33.0 (2.3, 4.2)3.3 (2.4, 4.6)0.134
Neutrophil count (109/L)31.8 (1.3, 2.6)1.9 (1.4, 2.7)0.623
Hemoglobin (g/dL)310.5 ± 2.410.7 ± 2.30.202
Platelet count (109/L)366.0 (43.0, 103.8)69.0 (44.0, 123.8)0.300


Write to the Help Desk